Zhejiang Huahai Pharmaceutical Co Ltd (600521) - Total Liabilities
Based on the latest financial reports, Zhejiang Huahai Pharmaceutical Co Ltd (600521) has total liabilities worth CN¥11.55 Billion CNY as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Huahai Pharmaceutical Co Ltd - Total Liabilities Trend (2000–2024)
This chart illustrates how Zhejiang Huahai Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Huahai Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Huahai Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhende Medical Co Ltd
SHG:603301
|
China | CN¥2.42 Billion |
|
Guaranty Trust Holding Co. PLC GDR
LSE:GTCO
|
UK | $13.29 Trillion |
|
BILL Holdings, Inc.
SA:B2HI34
|
Brazil | R$6.32 Billion |
|
Danieli & C RSP
LSE:0N4I
|
UK | €3.44 Billion |
|
China Everbright Environment Group Limited
F:CNE
|
Germany | €121.69 Billion |
|
Jiangsu Phoenix Publishing & Media Corp Ltd
SHG:601928
|
China | CN¥11.19 Billion |
|
Ninestar Corp
SHE:002180
|
China | CN¥7.78 Billion |
|
MANDARIN ORIENTAL DL-05
F:1C4
|
Germany | €918.90 Million |
Liability Composition Analysis (2000–2024)
This chart breaks down Zhejiang Huahai Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Huahai Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Huahai Pharmaceutical Co Ltd (2000–2024)
The table below shows the annual total liabilities of Zhejiang Huahai Pharmaceutical Co Ltd from 2000 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥11.24 Billion | +8.62% |
| 2023-12-31 | CN¥10.35 Billion | -0.55% |
| 2022-12-31 | CN¥10.41 Billion | +19.72% |
| 2021-12-31 | CN¥8.69 Billion | +38.70% |
| 2020-12-31 | CN¥6.27 Billion | +26.58% |
| 2019-12-31 | CN¥4.95 Billion | -19.64% |
| 2018-12-31 | CN¥6.16 Billion | +91.80% |
| 2017-12-31 | CN¥3.21 Billion | +49.50% |
| 2016-12-31 | CN¥2.15 Billion | +19.69% |
| 2015-12-31 | CN¥1.80 Billion | +44.31% |
| 2014-12-31 | CN¥1.24 Billion | -14.02% |
| 2013-12-31 | CN¥1.45 Billion | +14.14% |
| 2012-12-31 | CN¥1.27 Billion | +21.01% |
| 2011-12-31 | CN¥1.05 Billion | +42.33% |
| 2010-12-31 | CN¥735.92 Million | +40.72% |
| 2009-12-31 | CN¥522.98 Million | +26.17% |
| 2008-12-31 | CN¥414.51 Million | +44.04% |
| 2007-12-31 | CN¥287.78 Million | +29.25% |
| 2006-12-31 | CN¥222.66 Million | +28.92% |
| 2005-12-31 | CN¥172.70 Million | +56.97% |
| 2004-12-31 | CN¥110.03 Million | +23.25% |
| 2003-12-31 | CN¥89.27 Million | -46.75% |
| 2002-12-31 | CN¥167.62 Million | +10.48% |
| 2001-12-31 | CN¥151.72 Million | +34.52% |
| 2000-12-31 | CN¥112.79 Million | -- |
About Zhejiang Huahai Pharmaceutical Co Ltd
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and pol… Read more